Has Eric Felner received payments from drug or device companies?

Yes. Drug and device makers reported $23,841 in general payments to Eric Felner across 17 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eric Felner did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eric Felner come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eric Felner

Pediatric Endocrinology · Atlanta, GANPI 1972545457

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $21,235 of the $23,841 with a category attached, or 89.1%. 6 manufacturers reported payments, led by Soleno Therapeutics, Inc. at 36.0% of the total. 2025 is the largest year on record at $9,185, 7.7 times the $1,200 reported in 2020. Among pediatric endocrinology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,841in general payments, 2019–2025

Across 17 payments — averaging $1402.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Soleno Therapeutics, Inc.$9K
Ipsen Bioscience Inc.$7K
Novo Nordisk$6K
Pfizer$1K
Eton Pharmaceuticals, Inc.$1K
AbbVie$12

$1,362,486in research payments, 2019–2025

Across 107 payments — averaging $12,734 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Soleno Therapeutics, Inc.$556K
Neurocrine Biosciences, Inc.$244K
Astrazeneca UK Limited$176K
Pfizer$126K
Janssen Research & Development, LLC$110K
Aeterna Zentaris Inc.$73K
plus $77K from 2 others

What the payments were for

Consulting fees$21,23589%
Speaking & faculty fees$1,6097%
Travel & lodging$5822%
Food & beverage$4152%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Soleno Therapeutics, Inc.	10	$8,594
Ipsen Bioscience Inc.	1	$7,410
Novo Nordisk	2	$5,625
Pfizer	2	$1,200
Eton Pharmaceuticals, Inc.	1	$1,000
AbbVie	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VYKAT XR$8,034
Alkindi$1,000
KHINDIVI$1,000
INCRELEX$1,000

How this compares

$23,841 in reported general payments places this provider in the 90th percentile of 30 pediatric endocrinology providers in Georgia.

See all pediatric endocrinology providers in Georgia →

Other pediatric endocrinology in Atlanta

Quentin VanmeterAtlanta$215K
Daniel HsiaAtlanta$6K
Kristina CossenAtlanta$2K
Stephen AndersonAtlanta$1K
Andrew MuirAtlanta$1K
Marjorie GolekohAtlanta$808
Rajeev ThirunagariAtlanta$463
Noreen IslamAtlanta$356
Mark RappaportAtlanta$306
Malinda WuAtlanta$243

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →